Teva pharmaceutical sees revenue grow in first quarterThursday 01 May 2014 16.16
Pharmaceutical group Teva has reported revenues of $5bn for the first three months of 2014; up 2% on the same period of last year.
The company, which employs 467 at facilities in Dundalk and Waterford, also said it was now the largest supplier of prescription medicines in Ireland; distributing 11,000 packs of medicine per day.
Teva, which produces a range of products including cancer therapies and oral contraceptives, recorded an income of $744m during the quarter when using generally accepted accountancy principles.
This was an increase of 18% on the income it generated in the first three months of 2013.
Based on this the company has reaffirmed its full year and earnings-per-share guidance for 2014.